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Background: Children who were <1000 g (ELBW extremely low birth weight) at birth more frequently present with
wheezing which is the most common reason that pediatric consultation is sought. Therefore asthma is diagnosed
very often. However is the asthma that is diagnosed in ELBW subjects atopic in origin, or is there a different
etiology?
Aim: To determine if ELBW infants are at higher risk for the development of allergic and respiratory symptoms and
to establish if there were any specific risk factors for these symptoms.
Methods: 81 children born with a mean birthweight of 845 g (91% of available cohort) were evaluated at the
mean age 6.7 years. The control group included 40 full-term children. The children were examined for clinical signs
of allergy, and were subjected to the following tests: serum total IgE, skin prick tests (SPT), exhaled nitric oxide
measurement (FeNO) and spirometry.
Results: ELBW children had wheezing episodes more often (64% vs. 25%; OR (odds ratio): 5.38; 95% CI (confidence
interval): 2.14-13.8) and were diagnosed more frequently with asthma (32% vs. 7.5%; OR: 5.83, 95% CI: 1.52-26) than
their term born peers. The most important risk factors for wheezing persistence were hospitalization and wheezing
episodes in first 24 months of life. Mean serum tIgE level (geometric mean: 32+/−4 vs. 56+/−4 kU/L; p=0.002) was
higher and the number of children with positive results of tIgE level (12% vs. 32%; p=0.02) were more frequent in
the control group. Children from the control group also more frequently had SPT, however this data was not
statistically significant (11% vs. 24%; p=0.09). All of the ELBW had normal FeNO level (<=20 ppb), but 5 children
from the control group had abnormal results (p=0.02). There was no difference between the groups in the
occurrence of allergic symptoms.
Conclusion: ELBW children have more frequent respiratory, but not allergic problems at the age of 6–7 years
compared to children born at term. The need for rehospitalization in the first 2 years of life, was a more important
risk factor of future respiratory problems at the age of 7 than perinatal factors, the diagnosis of bronchopulmonary
dysplasia or allergy.
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Despite improvements in perinatal care, the incidence of
late complications of prematurity is not decreasing. On
the other hand what is increasing is the survival of
ELBW infants [1] which due to innovations in neonat-
ology/perinatology in the past years such as less invasive
treatment strategies aimed at the restriction of excessive
oxygen and ventilation, a decrease in postnatal infections
and the improvement of nutrition [2] are a completely
different population from the ELBW infants of 30 years
ago and in consequence require ongoing follow-up and
analysis. ELBW infants are also a very distinct popula-
tion that usually have the most severe complications of
prematurity (such as respiratory distress syndrome, pa-
tent ductus arteriosus, intraventricular hemorrhage, sep-
sis and necrotizing enterocolitis), which unfortunately
continue to cause health problems later in life. The
morbidity and mortality of these complications is highest
in infants born at the threshold of viability [3]. In this
study we decided to focus on respiratory problems because
they contribute significantly to the morbidity of prema-
turely born children and usually persist at least until school
age. Furthermore, it is very likely, that some patients who
go on to have respiratory diseases in adulthood have a his-
tory of premature birth [4,5]. Children who were <1501 g
at birth also more frequently present with wheezing [6]
which has been shown to be the most common reason that
parents seek pediatric consultation. Therefore asthma is
diagnosed very often, particularly in children born prema-
turely and in consequence they are often treated with anti-
allergic and antiasthmatic medications (inhaled or nasal
steroids, antihistamines, leukotriene antagonists).
However is the asthma that is diagnosed in ELBW sub-
jects atopic in origin, or does it have a different etiology
altogether? Baraldi and colleagues [7] recently showed that
nitric oxide fraction in exhaled air (FeNO) values which
are an indirect marker of eosinophilic airway inflammation
were lower in preterm children than in those with asthma
and even as much as four times lower in children with
BPD. There are also investigations proving that prematur-
ity reduces the long-term risk of atopy [8-10], and the oc-
currence of diseases such as allergic rhinitis, eczema and
atopic asthma. We will try to cover these and many other
issues in this study which deals with the the respiratory
and allergic outcomes of babies born with a gestational age
<30 weeks and birth weight <1000 g (ELBW) compared to
term-born children at the age of 6–7 years. Most studies
related to this subject up to date have included VLBW sub-
jects, so this study is a rare opportunity to see how these
problems evolve in the population of ELBW children.
Material and methods
A cross-sectional observational study was conducted in the
Follow-up Pediatric Department of the Polish-AmericanChildren’s Hospital between August 1, 2009 and October
31, 2010.
From the 1 of September 2002 to the 31 of August 2004
one hundred and sixty-nine newborns with birth weights
from 500 to 1000 g were born alive in the south-east
district of Poland (Małopolska region). All children were
hospitalized in three tertiary care Neonatal Intensive Care
Units (NICU) in south-east Poland. Ninety-one infants
were discharged home from the NICU. The children who
were still alive at the age of 6–7 years were invited to
participate in the follow-up study (n=89). Neonatal data
used for the study was recorded daily during their
hospitalization in the NICU in a prospective manner and
stored in computer databases. For the purpose of the study
the following data was extracted from the original data-
bases: sex, birthweight, gestational age, intrauterine growth
parameters, Apgar score, incidence of preeclampsia, pre-
term rupture of membranes, chorionamnionitis, presence
of respiratory distress syndrome (RDS), need for mechan-
ical ventilation, surfactant administration, use of ibuprofen
for patent ductus arteriosus (PDA), PDA ligation, early-
and late-onset septic episodes, prevalence of intraventricu-
lar hemorrhage (IVH), periventricular leukomalacia (PVL),
bronchopulmonary dysplasia (BPD) - defined as at least 28
days of oxygen therapy, moderate and severe BPD defined
as oxygen therapy at 36 weeks post menstrual age (PMA),
weight gain during NICU stay and length of hospitalization.
The control group included age-matched children
from one general practitioners (GP) office. 42 children
in total fulfilled the qualifying criteria of the study, the
majority of parents agreed to let their children partici-
pate in the study (n=40), only 2 declined.
The study was approved by the Ethical Committee
for Clinical Investigations of Collegium Medicum,
Jagiellonian University.
After signing an informed consent, parents were asked
to complete two questionnaires: 1/ including demographic
variables, family characteristics (education level, health
status, place of residence (city/rural area), parental atopy
status), nutrition during the first year of life (breast-feed-
ing/formula feeding), environmental risk factors of allergy
(parental smoking habits, siblings, day care attendance,
home pets), history of treatment and hospitalizations due
to respiratory problems; 2/ validated, standardized ISAAC
(International Study of Asthma and Allergies in Child-
hood) questionnaire assessing allergic disorders [11]. All
questions were verified by a physician during face-to-face
discussion. Afterwards, all children were examined by an
investigator for the presence of atopic eczema, (rhino)con-
junctivitis, wheezing, and other clinical signs of allergy.
Laboratory evaluation
After the examination, a venous blood sample (3 ml)
was taken for the assessment of absolute eosinophil
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sured using the immunofluorometric method (Immuno-
CAP, Phadia AB, Sweden) with an assay sensitivity range
of 2–5000 kU/L. Serum tIgE levels above the upper limit
for age of the patient were recognized as a positive re-
sult. Absolute eosinophil counts were calculated accord-
ing to standard hospital laboratory methods.
During the same visit skin prick tests (SPT) were
performed in a typical manner, for the following 10
allergens (Allergopharma, Germany): indoor allergens -
house dust mites (D. pteronyssimus, D. farine), dog, cat,
molds (Alternaria, Aspergillus, Cladosporium), outdoor
allergens – grasses, trees, weeds. A reaction to an aller-
gen was regarded positive if the mean wheal diameter
was at least 3 mm. Atopy was defined as a positive SPT
to at least one of the aeroallergens.
Exhaled nitric oxide
Exhaled nitric oxide (FeNO) was measured in concord-
ance with published standards [12], using an electro-
chemical hand-held device - NIOX MINOW (Airway
Inflammation Monitor /NIOX MINO/, Aerocrine AB,
Solna, Sweden), following the producers instructions,
with exhaled air flows equal to 50±5 ml/s. Measure-
ments of FeNO were performed prior to all other study
procedures.
FeNO results were evaluated according to the guide-
lines by Taylor et al. in which - levels equal or below
20 ppb were regarded as normal [13].
Lung function
Spirometry was performed using a Lungtest 1000 spir-
ometer with a pneumotachometer-based system (MES,
Kraków, Poland). The forced vital capacity (FVC), forced
expiratory volume in one second (FEV1), ratio of FEV1/
FVC and the forced expiratory flow at 50% of FVC (FEF50)
was measured before and after the inhalation of 400 ug of
salbutamol, according to the recommendations of ATS/
ERS [14]. Results are presented as percent of predicted
values with reference values of Zapletal et al. [15]. Bron-
chodilator response was estimated and expressed as the
percentage of FEV1, FEF50 increase after salbutamol inhal-
ation (Δ%FEV1, Δ%FEF50). A Δ%FEV1 of more than >12%
was considered a significant bronchodilator response.
Outcome variables
The primary outcomes at the age of 7 years were the
presence of respiratory and allergic problems defined as
a positive response to the ISAAC questionnaire pertain-
ing to : 1) wheezing in the last year, 2) sneezing or a
runny or blocked nose with itchy-watery eyes without
cold or flu in the last year (rhinoconjuctivitis in the last
year), 3) itchy rash in the last year with any flexural in-
volvement or located around the neck, ears or eyes(eczema symptoms in the last year), 4) any wheezing
episode in the past (wheeze ever), 5) the diagnosis of
asthma (asthma) 6) hay fever/allergic rhinitis (allergic rhin-
itis), or 7) eczema by a doctor in the past (eczema). More-
over, we also asked: Has your child ever been hospitalized
due to respiratory problems? (hospitalizations ever), Was
your child hospitalized due to respiratory problems in the
its first 24 months of life? (hospitalization in the first 24
months of life), Was your child hospitalized for respiratory
problems in the last year? (hospitalizations in the last year),
Is your child taking any respiratory or allergic medications?
(current medications).
Secondary outcome variables were positive results of
serum tIgE or SPT and the subject’s respiratory status
determined by spirometry results and FeNO.Statistical methods
In order to draw comparisons between the groups, the
following tests were utilized as was deemed appropriate:
Student’s t-test, ANOVA, Kruskal-Wallis test, chi square
test or Fisher’s exact test. Odds ratio (OR) and 95% con-
fidence interval (CI) were calculated for the risk of re-
spiratory and atopic problems.
Statistical significance was defined for two sided test at
the p=0.05 level. Data was analyzed using SAS Software
(2006 by SAS Institute Inc., Cary, NC, USA).
Sample size estimations were based on the assumption
that the follow-up rate among ELBW children would be
as high as 90% (80 ELBW children). The frequency of
primary endpoints was adopted on the basis of an
ISAAC study, in which the incidence of wheeze in the
last year, rhinoconjuctivitis in the last year, and eczema
symptoms in the last year ranged from 15 to 30%.
Assuming that the risk of type I error equaled to 5%
(two sided test) and the control group would include 40
children, a study with the power of 80% might demon-
strate a 15% difference in the incidence of primary end-
points between ELBW and control group subjects.
Sample size calculation was performed using PS Power
and Sample Size Calculations software (Version 2.1.30,
February 2003, http://www.mc.vanderbilt.edu/prevmed/
ps/index.htm)Results
Eighty-one children born as ELBW infants (91% of the
available cohort) with a mean birthweight of 849 g (SD:
131 g) and a mean gestational age of 27.2 weeks (SD: 2.1
weeks) were evaluated at a mean age of 6.7 years (SD: 0.4).
The control group included 40 full-term children. The
comparison of selected demographic variables between
the studied groups is shown in Table 1. Vaginal delivery
was more frequent in the control group. ELBW children
were more frequently small for gestational age than
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groups were similar with respect to age and gender.
The comparison of factors which could have an impact
on the respiratory system in the studied groups is shown
in the Table 1. There were no differences in number of
siblings, family history of atopy, history of passive smok-
ing, presence of any pets at home and place of residence.
Breast feeding after 1 month of life was less common in
the ELBW group, in addition 12% of them did not
attend school.
The results of the questionnaire relating to respiratory
and atopic problems are presented in Figure 1. Wheeze
ever was reported more frequently in the ELBW group
(64% of the ELBW vs 25% of control group, OR 5.38,
95% CI: 2.14-13.8), although in the last year that differ-
ence had decreased and was no longer statistically sig-
nificant (32% vs 20%). Asthma was diagnosed in a large
number of ELBW children (32% of ELBW vs 7.5% of the
control group, OR 5.83, 95% CI: 1.52-26). The majority
of ELBW children required hospitalization due to
respiratory problems (hospitalization ever: 60% of ELBW
vs 10% of control, OR 13.8, 95% CI: 4.13-51). The
hospitalization rate had decreased in the last year, never-
theless it was still four times higher in ELBW than in
the control group. The current use of antiallergic and
antiasthmatic medications (inhaled or nasal steroids,
antihistamines, leukotriene antagonists) was 2 timesTable 1 Comparison of selected demographic and clinical var
ELBW grou
Birth weight (g), mean (SD) 845 (130)
Gestational age (weeks), mean (SD) 27.2 (2.1)
Female 52 (64)
Vaginal delivery 17 (21)
Multiple pregnancy 10 (12)
Small for gestational age 24 (30)
5th min. Apgar score, Me; (25th -75th percentile) 6 (5–7)
Siblings 47 (58%)
School attendance 71 (88%)
Paternal history of atopy 14 (17%)
Pets at home 32 (39.5%)
Passive smoking
None 64
History 9
Current 8
Place of residence
City area 31
Rural area 50
aexpressed as a number (percentage) of patients unless otherwise indicated.
p value for ANOVAb, chi square testc, and Kruskal-Wallis testd.
ELBW – extremely low birth weight.higher in the ELBW group in comparison to the control
group (although this difference was not statistically sig-
nificant). There was no difference between the groups in
the occurrence of other allergic diseases or symptoms
such as: allergic rhinitis or eczema ever, rhinoconjuctivi-
tis, eczema symptoms in the last year (all symptoms
were less frequent in the ELBW group).
The results of laboratory tests in the studied groups
are presented in Table 2.
Spirometry was performed in 56% (45/81) of ELBW
children and in 80% (32/40) of children in the control
group (Figure 2). In 44% of ELBW children it was not
possible to perform the spirometry because of their
neurological complications or lack of child’s cooperation.
A quarter of the ELBW group (22/81) and half of the
control group (20/40) were able to perform acceptable
and repeatable spirometry that conformed to ATS/ERS
standards for this age group of children. The ELBW
children had a significantly lower FEV1 (Figure 3), FVC
and FEF50 compared to control subjects. FEV1 lower
than 80% of the predicted value was observed in up to
half of the ELBW group (10/22) and not in the control
group. The values of Δ%FEV1 and Δ%FEF50 were simi-
lar in both groups. A significant bronchodilator re-
sponse was observed in 4/22 of ELBW and in 1/20 of
control group subjects (difference between groups was
not statistically significant).iables between ELBW newborns and the control groupa
p (n=81) Control group (n=40) p value
3554 (512) <0.001b
39.9 (1.4) <0.001b
21 (53) 0.15c
34 (85) <0.001c
0 (0) <0.001c
2 (5) 0.003c
10 (9–10) <0.001d
27 (67.5%) 0.33c
40 (100%) 0.03c
3 (7.5%) 0.17c
13 (32.5%) 0.7c
32
1 0.16c
7
18 0.56c
22
Figure 1 Comparison of the presence of respiratory and atopic problems between the groups at 6–7 years of age.
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Appropriate maneuvers for FeNO measurements were
obtained in 22 ELBW children and in 20 of the controls.
All of the ELBW participants had normal FeNO levels
(≤20 ppb). Five children from the control group had ab-
normal results: 3 had results ranging from 20–35 ppb
and 2 above 35 ppb.
Atopy
Serum tIgE (geometric mean) and the number of chil-
dren with positive results of tIgE levels were more
frequent in the control group. Children from the control
group also more frequently had positive SPT, however
this data was not statistically significant. There was no
difference in absolute eosinophil counts between stud-
ied groups.
ELBW children with vs. without wheeze
Comparison of selected factors in ELBW children with
or without wheezing in the last year is presented in
Table 3. There were no differences between groups due
to: birth weight, gestational age, gender, length of mech-
anical ventilation, length of oxygen therapy and indica-
tors of bronchopulmonary dysplasia – oxygen therapy at
least 28 days and oxygen therapy at 36 weeks postmenstr-
ual age. The group of ELBW with wheezing in the last
year was characterized by more frequent wheezing in the
first 24 months of life and more hospitalizations due to re-
spiratory tract infections in that time period. There was
no difference regarding: family history of atopy, passive
smoking, pets at home, tIgE and positive SPT. The differ-
ence in the frequency of hospitalizations in last year, aswell as current medication use - were more frequent in
the group with wheeze in the last year. The spirometry
revealed no difference in FEV1 between both groups, but a
higher Δ%FEV1 in the group with wheeze in the last year.
Only in that group half of the children had an increase in
Δ%FEV1 greater than 12%.
AGA vs SGA infants
Furthermore we compared the incidence of complica-
tions in ELBW infants based on intrauterine growth
parameters, dividing the subjects into two groups: small
for gestational age (SGA) and appropriate for gestational
age (AGA). No significant differences were found in the
incidence of respiratory symptoms such as wheeze ever
or wheeze in the last year in SGA compared to AGA
subjects. The diagnosis of asthma was less common in
SGA subjects (25% compared to 35%) although this re-
sult was not statistically significant.The occurrence of al-
lergic symptoms in both groups were comparable (data
available on request). According to laboratory tests we
found a higher incidence of positive SPT and positive
results of tIgE levels in SGA compared to AGA partici-
pants although this was not statistically significant as
well (p=0.1).
Discussion
In this study we presented respiratory and allergic pro-
blems in the geographically based cohort of ELBW chil-
dren at the mean age of 6.7 years.
In our opinion, the study has significant value because:
1/ the study group included almost all newborns from
the whole Malopolska region born in a period of 2 years
Table 2 Laboratory tests results in the studied groups
ELBW
group
Control
group
p value
N=22 N=20
Spirometry and bronchial
responsiveness (expressed as
mean ± SD)
FEV1 (%) 81.3±13 95.8±8 <0.001
a
FVC (%) 79±13 89±7 <0.001a
MEF50 (%) 62±19 87±26 <0.001
a
Δ%FEV1 (%) 6.8±12.3 3.6±5.9 0.3a
Δ%MEF50 (%) 31±32 19±17 0.15a
FEV1 < 80% predicted value 10 (45%) 0 0.001
b
Δ%FEV1 >12% 4 (18%) 1 (5%) 0.3b
FeNO (ppb)
Median (25th-75th percentile) 8 (8–13) 10 (8–14) 0.2c
Normal (≤20 ppb) 22 15 0.02b
Intermediate (20–35 ppb) 0 3
High (>35 ppb) 0 2
N=81 N=40
serum tIgE (kU/L)
Geometric mean (± SD) 32±4 56±4 0.002a
High (>upper limit for age) 10 (12%) 12 (32%) 0.02b
Others
Absolute eosinophil count per uL) 265±202 225±185 0.3a
Positive SPT 8 (11%) 9 (24%) 0.09b
p value for ANOVAa, chi square testb, and Kruskal-Wallis test.
ELBW – extremely low birth weight.
SPT – skin prick test.
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multi-center study comes from all the tertiary referral
centers from the Malopolska region. It is a complete
group of patients with a high percentage of observation
(91%). 2/ The assessment of the past and current health
status of the child was based on a validated, standardized
ISAAC questionnaire and all responses were verified by
a physician. Moreover, all children were examined by an
investigator for the presence of symptoms characteristic
of eczema, rhinoconjunctivitis, wheezing, and other clin-
ical signs of allergic disorders. 3/ The current study lim-
ited the study group to ELBW children, most of the
previous studies included VLBW infants. 4/ Lung func-
tion was evaluated by spirometry according to the
recommendations of ATS/ERS published in 2005 [14].
5/ In addition, FeNO measurements which are a marker
of eosinophilic airway inflammation were done as well.
One of the major limitations of the study was the fact
that the spirometry results suitable for evaluation were
completed by only a quarter of the ELBW participants
(22/81) and half of the control group (20/40). Consideringthe fact that VLBW infants are at a greater risk of
neurodevelopmental delay, cerebral palsy, hearing im-
pairment and cognitive and emotional problems later in
life [16], cooperation in this group of children is a chal-
lenge and the achievement of reproducible spirometric
efforts is extremely difficult. Not to mention the fact
that this task can be sometimes difficult among term
born children as well.
One of the major results of this study was the observa-
tion that among ELBW subjects, the children with
wheezing episodes in the last year more often had the
need for hospitalization in the first 2 years of life com-
pared to other (non-wheeze in the last year) ELBW
children. Surprisingly we found no difference in birth
weight, gestational age, length of mechanical ventilation,
oxygen therapy in the first 28 days of life or at 36 weeks
PMA between ELBW children with and without wheeze
in last year. There was no significant difference in family
history of atopy, pets at home between ELBW children
with and without wheeze in last year. Furthermore those
children were not exposed more often to passive smok-
ing. Interestingly enough, positive SPT were not more
frequent and serum tIgE levels were not greater in the
ELBW population with wheeze in last year. Thus there
was no evidence of atopy contributing to persistent re-
spiratory problems in those children. The baseline FEV1
values were similar, but %FEV1 values were greater in
the ELBW children with wheeze in last year and in half
of them there was a significant bronchodilator response.
Our results suggest that symptoms of asthma observed
in the ELBW population correlated more strongly with
respiratory morbidity in infancy rather than perinatal
problems or atopic factors. We have shown that the
need for re-hospitalization in the first 2 years of life, was
a more important risk factor of respiratory problems at
the age of 7 than perinatal factors or the diagnosis of
bronchopulmonary dysplasia. Furman et al. [17] who
followed 98 out of 124 VLBW infants with BPD up to
the age of 2 years also showed that the severity of BPD
correlated with the duration of neonatal hospital stay
and total hospital stay during the first 2 years of life. A
similar finding was also mentioned in another study by
Ballow et al. [18] which followed 43 VLBW preterm
infants until 10 months chronological age and found
that they had a considerably higher incidence of infec-
tions (especially lower respiratory tract infections) than
term infants, what’s more none of them turned out to be
bacterial infections. Among lower respiratory tract infec-
tions RSV has been shown to be the most common
cause in high risk infants such as prematurely born
infants [19] in addition it has been shown preterm
infants are more likely to have a more severe clinical
course of the disease than term infants (more prolonged
hospital stays, requiring oxygen for longer periods of
Figure 2 Study flow-chart.
Figure 3 Comparison of forced expiratory volume
measurements between the group of extremely low
birthweight children and the group of full-term peers.
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airway pressure, CPAP, or mechanical ventilation) [20].
In light of these facts it is highly probable that the
increased hospitalisation rate in ELBW infants is not
only due to the immaturity of the lungs, not fully recov-
ered from the morbidity of the perinatal period but also
due to the damage to the lungs that is incurred with
each subsequent infection and also through the use of
respiratory support (volutrauma, barotrauma, oxygen
toxicity) causing a state of chronic inflammation and
lung injury.
Our study confirmed previous observations that
ELBW children had more frequent respiratory problems
at the age of 6–7 years compared to children born at
term. In ELBW children, wheeze in the last year or ever
in the past and an established diagnosis of asthma were
observed more frequently in these subjects than in their
peers. The need for hospitalization due to respiratory
disease at any time was significantly higher in the ELBW
population. This tendency was also present in the last
year, however it did not have full statistic significance.
However the results of the pulmonary function tests
were significantly poorer in ELBW subjects than in con-
trols. This explains why the use of medications – first
and foremost- inhaled steroids were more common in
the ELBW group. The need for hospital admissions also
suggested that the severity of respiratory disease was
greater in ELBW children. Fortunately there has been a
decrease in the need for hospitalization in the last year.
Similar observations have been noted in others studies.
McLeod et al. studied a group of very low birth weight
(VLBW) children who were evaluated at the age of 8–9
years and reported that they used inhaled drugs and
were admitted to hospital more often than their classroompeers [21]. Siltanen et al. reported an increased prevalence
of wheezing in preterm infants (43%) at the age of 10 years
compared to term-born subjects (17%) [22]. A reduction
in the number of hospital admissions after the second year
of life, including children with BPD, was reported in an-
other study [23].
Martinez et al. reported that children who started
wheezing early in life and continued to wheeze at the
Table 3 Comparison of selected factors between the group of ELBW infants with and without wheeze in the last year
Without wheeze in last year (n=55) Wheeze in the last year (n=26) p value
Perinatal factors
Birth weight (g), mean (SD) 853±139 830±159 0.8a
Gestational age (weeks), mean (SD) 27.3±2.1 27.3±2.6 0.9a
Female 37 (67%) 15 (58%) 0.5b
Length of mechanical ventilation (Me; 25-75th percentile) (days) 17 (2–48) 24 (6–39) 0.8c
Length of oxygen therapy (Me; 25-75th percentile) (days) 44 (13–77) 55 (34–74) 0.9c
Oxygen therapy at least 28 days 34 (62%) 19 (73%) 0.5b
Oxygen therapy at the 36 PMA 21 (38%) 10 (38%) 1.0b
Infancy
Wheeze in the first 24 months of life 29 (53%) 21 (81%) 0.03b
Hospitalization in the first 24 months of life 25 (45%) 19 (73%) 0.03b
Immunoprophylaxis with palimivizumab 8 (15%) 2 (8%) 0.5b
Atopy
Parental history of atopy 9 (17%) 5 (22%) 0.8b
Passive smoking 4 (7%) 4 (15%) 0.26b
Pets at home 21 (40%) 11 (48%) 0.7b
serum tIgE (Me; 25-75th percentile) 22 (12–68) 34 (12–73) 0.3c
Absoulte eosinophil count (eos/uL 230±137 338±275 0.03a
Positive SPT 4 (7%) 4 (15%) 0.26b
Recent status
Hospitalization in the last year 2 (4%) 12 (46%) <0.01b
Current medications 11 (20%) 15 (58%) 0.002b
FEV1 (%) 80±13 83±16 0.61
a
Δ%FEV1 (%) 1±7 16±13 0.002a
Δ%FEV1 >12% 0/14 4/8 (50%) 0.01b
p value for ANOVAa, chi square testb, and Kruskal-Wallis test.
ELBW – extremely low birth weight.
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of asthma and elevated serum tIgE. However, the gesta-
tional age of the subjects was not revealed in that study
[24]. In our population the ELBW children did not
present with: allergic rhinitis, rhinoconjunctivitis or
eczema more frequently than their term born peers.
Bűhrer et al. also showed a decreased prevalence of
atopic eczema in VLBW infants compared to term and
near-term infants in the first year of life suggesting that
early antigen exposure in VLBW infants could lead to
tolerance and a decreased risk of sensitization [25].
Risk factors of allergy development such as: family his-
tory of atopy, exposure to tobacco smoke, contact with
animals (pets at home, indoor allergens), place of resi-
dence, presence of siblings at home were similar in both
groups. The only differentiating factor was duration of
breast feeding, which in ELBW children frequently
lasted less than one month, meanwhile breast feeding
lasting more than 4 months has been proven to reduce
the risk of asthma at the age of 6 years [26].Asthma was diagnosed more often in the ELBW group
(32%) than in the control group (7.5%). In other reports,
asthma was also diagnosed more frequently in ELBW
children (24.7%) than in controls (13.9%) at the age of
8–9 years [27] and 28% vs 14% at the age of 10 years, re-
spectively [28]. Large-scale analysis conducted by Brooks
et al. confirmed a strong independent association be-
tween low birth weight and asthma, diagnosed by a
physician at the age of 3 years [29]. It is important to
note, that the prevalence of asthma in our controls cor-
responded with the results of the ISAAC survey of 6–7
year old children in a proper geographic region [11].
Siltanen et al. reported that atopy was more frequent
in term than in the ELBW infants, and reduced pulmon-
ary function in that group was not related to atopy
[9,10,22]. Mieskonen et al. showed that atopy was less
common in VLBW children with BPD than without
BPD, furthermore atopic children had higher birth
weights, a shorter need for ventilator and oxygen ther-
apy than non-atopic children born prematurely [30]. In
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frequently above the upper limits for age in the control
group. The SPT were also more frequently positive in
the control group, but the difference was not statistically
significant. Thus, we can conclude that symptoms of
asthma in our cohort of ELBW children were not asso-
ciated with atopy.
In our study FEV1 below 80% of predicted value was
observed in the nearly half of ELBW children and not in
the control subjects. Similar observations were made in
children with symptoms suggestive of asthma and bronch-
opulmonary dysplasia [31].
Doyle et al. reported that all respiratory function vari-
ables reflecting airflow were diminished in the ELBW
group compared to term-born controls at the age of 8–9
years (reduction in FEV1 below 75% was observed in
19.7% ELBW children vs 2.4% in control subjects) [27].
Mieskonen et al. reported that BPD and non-BPD VLBW
children had significantly lower FVC, FEV1, FEF50 than
controls, but the BPD VLBW children had significantly
lower values than non-BPD VLBW at 8 years of age [30].
Mai et al. evaluated VLBW compared to term children at
the age of 12 years, a history of asthma was more fre-
quently noted in VLBW children and the only significant
risk factor was prolonged oxygen therapy. Spirometric
values were similar among VLBW and term children [8].
The improvement in spirometry results (FEV1) obtained
in VLBW subjects between 6 and 12 years of age indicated
that there was an acceleration of the lung development, al-
though they did not catch up with their peers in weight
and height [8,28].
Eosinophilic airway inflammation was assessed by meas-
urement of FeNO. Atopy and atopic asthma leads to the
increase in FeNO levels [30,32]. Diminished levels of
FeNO were observed in children with virus-associated
acute wheezy bronchitis [33]. The level of FeNO corre-
lated with BAL fluid or sputum eosinophil percentage, but
not with other inflammatory cells, and is considered to be
a marker of eosinophilic inflammation [34,35]. A relation-
ship between FeNO and blood eosinophils was also con-
firmed [32]. In our study, the FeNO levels were not higher
in the ELBW population (particularly not greater than
20 ppb), which can indicate the absence of an eosinophilic
inflammatory process in their respiratory tract. However,
we could not exclude the effect of inhaled steroids on
FeNO levels in some patients. Glucocorticosteroids de-
crease FeNO in asthmatic, but not healthy subjects [31].
Baraldi et al. showed that FeNO was significantly lower in
VLBW children with BPD than in VLBW without BPD
(however, all results were below 11 ppb) [7]. Mieskonen
et al. found no significant differences in FeNO levels
between BPD and non-BPD non-atopic subjects [30]. Both
authors revealed no difference in FeNO between VLBW
children and healthy controls. The atopic VLBW childrenhad significantly higher FeNO levels (mean 14.8 ppb) than
non-atopic prematurely born subjects (mean 6.3 ppb),
although it was not significantly higher than healthy term
controls (mean 6.4 ppb) [30]. These authors found that
flow limitation was not associated with increased NO
production and lack of reversibility of airflow limitation
and low FeNO values suggested different than asthma
mechanism of lower forced expiratory flows. We had
similar observations.
Conclusions
In summary we demonstrated that respiratory problems
were more frequent in ELBW children at the age of 6–7
years compared to children born at term. ELBW chil-
dren had more episodes of wheezing, were more fre-
quently diagnosed with asthma and had decreased
spirometry parameters compared to their peers. The
need for hospital admissions due to respiratory problems
was also greater in the ELBW population (although it
had decreased in the last year) as was the use of medica-
tions, especially inhaled steroids.
However the occurrence of other allergic diseases such
as allergic rhinitis, or eczema was not observed more fre-
quently in the ELBW population, nor were symptoms of
rhinoconjunctivitis, eczema in the last year. We also did
not show an elevation of FeNO in ELBW children which
can be assumed as a surrogate of eosinophilic airway in-
flammation. Mean serum tIgE levels were higher and the
number of children with positive results of tIgE levels
were more frequent in the control group. Children from
the control group also more frequently had positive SPT,
however this data was not statistically significant.
On the other hand we found that the need for re-
hospitalization in the first 2 years of life was the most
important risk factor for the occurrence of respiratory
problems at the age of 6–7 years, even more relevant
than perinatal factors and the diagnosis of bronchopul-
munonary dysplasia. A lot of the studies mentioned in
the discussion as well as our own results have shown a
decreasing tendency of respiratory problems in ELBW
children as they grow up. Longitudinal follow up studies
are needed to determine whether this trend will con-
tinue but also whether these subjects will be more sus-
ceptible to developing pulmonary disease later in life
such as COPD (Chronic obstructive pulmonary disease).
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